Prognostic Value of PRECİSE DAPT Score in MINOCA Patients with Acute Coronary Syndrome.
作者信息
Bianco Henrique Tria
机构信息
Universidade Federal de São Paulo (UNIFESP), São Paulo, SP - Brasil.
出版信息
Arq Bras Cardiol. 2024 Jul 15;121(5):e20240307. doi: 10.36660/abc.20240307. eCollection 2024.
Abstract
摘要
相似文献
1
Prognostic Value of PRECİSE DAPT Score in MINOCA Patients with Acute Coronary Syndrome.PRECİSE DAPT评分在急性冠状动脉综合征的心肌梗死伴非阻塞性冠状动脉病变（MINOCA）患者中的预后价值
Arq Bras Cardiol. 2024 Jul 15;121(5):e20240307. doi: 10.36660/abc.20240307. eCollection 2024.
2
Use of PRECISE-DAPT Score and Admission Platelet Count to Predict Mortality Risk in Patients With Acute Coronary Syndrome.使用PRECISE-DAPT评分和入院血小板计数预测急性冠状动脉综合征患者的死亡风险。
Angiology. 2019 Oct;70(9):867-877. doi: 10.1177/0003319719848547. Epub 2019 May 14.
3
Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.PRECISE-DAPT 评分预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者出血事件的临床价值：来自 SMART-DATE 随机试验的分析。
Circ Cardiovasc Interv. 2020 May;13(5):e008530. doi: 10.1161/CIRCINTERVENTIONS.119.008530. Epub 2020 May 1.
4
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor.比较 PRECISE-DAPT 和 PARIS 风险评分在接受普拉格雷或替格瑞洛治疗的 4424 例急性冠脉综合征患者中的外部验证。
Int J Cardiol. 2020 Feb 15;301:200-206. doi: 10.1016/j.ijcard.2019.11.132. Epub 2019 Nov 22.
5
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.急性冠脉综合征未行血运重建治疗后双联抗血小板治疗的长期出血风险预测
Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e006582. doi: 10.1161/CIRCOUTCOMES.120.006582. Epub 2020 Aug 31.
6
Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?对于伴有 NSTEACS 的糖尿病患者，是否应将 PRECISE-DAPT 纳入长期预后分层？
Acta Diabetol. 2022 Feb;59(2):163-170. doi: 10.1007/s00592-021-01792-w. Epub 2021 Sep 13.
7
Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients.评估 PRECISE-DAPT 和 PARIS 风险评分在预测急性冠脉综合征患者一年外出血中的表现。
EuroIntervention. 2018 Mar 20;13(16):1914-1922. doi: 10.4244/EIJ-D-17-00550.
8
The predictive value of PRECISE-DAPT score for long-term mortality in patients with acute coronary syndrome complicated by cardiogenic shock.PRECISE-DAPT 评分对合并心原性休克的急性冠状动脉综合征患者长期死亡率的预测价值。
Herz. 2024 Aug;49(4):302-308. doi: 10.1007/s00059-023-05231-0. Epub 2024 Jan 3.
9
Bleeding risk in patients with acute coronary syndrome in a Turkish population: Results from the Turkish Acute Coronary Syndrome Registry (TACSER) study.土耳其急性冠脉综合征注册研究（TACSER）：土耳其人群中急性冠脉综合征患者的出血风险。
Eur J Clin Invest. 2020 Nov;50(11):e13271. doi: 10.1111/eci.13271. Epub 2020 Jun 27.
10
Outcomes in Patients Stratified by PRECISE-DAPT Versus DAPT Scores After Percutaneous Coronary Interventions.经皮冠状动脉介入治疗后根据PRECISE-DAPT评分与DAPT评分分层的患者结局
Am J Cardiol. 2021 Dec 15;161:19-25. doi: 10.1016/j.amjcard.2021.08.055.
本文引用的文献
1
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.PRECISE-DAPT 评分用于预测双联或单联抗血小板治疗患者的出血风险：来自 GLOBAL LEADERS 和 GLASSY 的研究结果。
Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):28-38. doi: 10.1093/ehjcvp/pvaa106.
2
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义（2018年）。
Circulation. 2018 Nov 13;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617.
3
Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA).评估心肌梗死且冠状动脉无阻塞（MINOCA）的患者。
J Intern Med. 2013 Feb;273(2):182-5. doi: 10.1111/j.1365-2796.2012.02591.x. Epub 2012 Oct 11.
4
Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.验证在接受经皮冠状动脉介入治疗的冠心病患者中使用 Bleeding Academic Research Consortium 定义的出血标准。
Circulation. 2012 Mar 20;125(11):1424-31. doi: 10.1161/CIRCULATIONAHA.111.060871. Epub 2012 Feb 17.
5
Recommendations for the use of cardiac troponin measurement in acute cardiac care.急性心脏护理中心肌钙蛋白检测的应用建议。
Eur Heart J. 2010 Sep;31(18):2197-204. doi: 10.1093/eurheartj/ehq251. Epub 2010 Aug 3.
6
Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study.冠状动脉痉挛作为急性冠状动脉综合征的常见病因：CASPAR（急性冠状动脉综合征患者的冠状动脉痉挛）研究
J Am Coll Cardiol. 2008 Aug 12;52(7):523-7. doi: 10.1016/j.jacc.2008.04.050.
7
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.非ST段抬高型心肌梗死且冠状动脉疾病不显著患者的患病率、预测因素及预后：来自“不稳定型心绞痛患者快速风险分层能否通过早期实施ACC/AHA指南抑制不良结局（CRUSADE）倡议”的结果
Am Heart J. 2006 Oct;152(4):641-7. doi: 10.1016/j.ahj.2006.02.035.
8
Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography.急性冠状动脉综合征管理中未解决的问题：冠状动脉造影显示疾病轻微或结果正常的患者的风险分层
Arch Intern Med. 2006 Jul 10;166(13):1391-5. doi: 10.1001/archinte.166.13.1391.
9
Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease.冠状动脉痉挛作为急性冠状动脉综合征且冠状动脉疾病不显著患者中心脏肌钙蛋白I升高的可能原因。
Am Heart J. 2002 Aug;144(2):275-81. doi: 10.1067/mhj.2002.123843.
10
Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients.冠状动脉造影完全正常的心肌梗死的临床特征、病因及长期预后：91例患者的3年随访研究
Eur Heart J. 2001 Aug;22(16):1459-65. doi: 10.1053/euhj.2000.2553.
Zotero 插件